BMRN vs TMP
Biomarin Pharmaceutical Inc (BMRN) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the BMRN and TMP stock pages for the full models.
Not investment advice.